ZA907702B - The use of alkylphosphoric acid compounds for combatting psoriasis disorders - Google Patents

The use of alkylphosphoric acid compounds for combatting psoriasis disorders

Info

Publication number
ZA907702B
ZA907702B ZA907702A ZA907702A ZA907702B ZA 907702 B ZA907702 B ZA 907702B ZA 907702 A ZA907702 A ZA 907702A ZA 907702 A ZA907702 A ZA 907702A ZA 907702 B ZA907702 B ZA 907702B
Authority
ZA
South Africa
Prior art keywords
combatting
acid compounds
alkylphosphoric acid
psoriasis disorders
psoriasis
Prior art date
Application number
ZA907702A
Other languages
English (en)
Inventor
Juergen Engel
Engel Juergen
Hansjoerg Eibl
Eibl Hansjoerg
Clemens Under
Under Clemens
Original Assignee
Asta Pharma Ag
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6390272&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA907702(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Pharma Ag, Max Planck Gesellschaft filed Critical Asta Pharma Ag
Publication of ZA907702B publication Critical patent/ZA907702B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA907702A 1989-09-27 1990-09-26 The use of alkylphosphoric acid compounds for combatting psoriasis disorders ZA907702B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3932183 1989-09-27

Publications (1)

Publication Number Publication Date
ZA907702B true ZA907702B (en) 1991-07-31

Family

ID=6390272

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA907702A ZA907702B (en) 1989-09-27 1990-09-26 The use of alkylphosphoric acid compounds for combatting psoriasis disorders

Country Status (17)

Country Link
EP (2) EP0419998A3 (xx)
JP (1) JP3176615B2 (xx)
CA (1) CA2026278C (xx)
DD (1) DD298052A5 (xx)
DE (1) DE4029747C2 (xx)
EG (1) EG19338A (xx)
FI (1) FI904726A0 (xx)
HU (1) HU209589B (xx)
IE (1) IE903464A1 (xx)
LT (1) LT3804B (xx)
LV (1) LV10391B (xx)
MC (1) MC2150A1 (xx)
NO (1) NO904184L (xx)
PT (1) PT95422B (xx)
RU (1) RU1837877C (xx)
UA (1) UA19335A (xx)
ZA (1) ZA907702B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958906A (en) * 1992-10-01 1999-09-28 Asta-Medica Aktiengesellschaft Phospholipid derivatives containing higher elements of the fifth main group
DE4233044A1 (de) * 1992-10-01 1994-04-07 Asta Medica Ag Phospholipidderivate, die höhere Elemente der V. Hauptgruppe enthalten
DE4235911A1 (de) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
CN100413492C (zh) * 1998-01-22 2008-08-27 赞塔里斯有限公司 口服给药治疗利什曼病的含有米替福星的固体药物组合物
DE102006004821B4 (de) * 2006-01-30 2020-12-10 Cuma Kilic Sammelbehältnis für Abfall und Bauschutt
BR112012000476A2 (pt) * 2009-07-09 2016-11-22 Expergen Drug Dev Gmbh forma farmacêutica líquida de alquilfosfocolina e método de preparação da mesma.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
IE59777B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicaments
DE3829899C2 (de) * 1988-09-02 1994-12-15 Reutter Werner Glyceringlycophosphatide und diese enthaltende pharmazeutische Mittel zur Bekämpfung von Hauterkrankungen

Also Published As

Publication number Publication date
EP0419998A3 (en) 1991-10-23
MC2150A1 (fr) 1992-03-10
PT95422B (pt) 1997-07-31
DE4029747C2 (de) 2003-10-02
LV10391A (lv) 1995-02-20
HUT55992A (en) 1991-07-29
EP0419998A2 (de) 1991-04-03
DD298052A5 (de) 1992-02-06
LT3804B (en) 1996-03-25
NO904184D0 (no) 1990-09-26
FI904726A0 (fi) 1990-09-26
DE4029747A1 (de) 1991-04-11
LV10391B (en) 1995-10-20
CA2026278A1 (en) 1991-03-28
NO904184L (no) 1991-04-02
UA19335A (uk) 1997-12-25
RU1837877C (ru) 1993-08-30
HU209589B (en) 1994-08-29
CA2026278C (en) 1996-04-30
LTIP1488A (en) 1995-06-26
JPH03130228A (ja) 1991-06-04
EP0916343A1 (de) 1999-05-19
HU906233D0 (en) 1991-03-28
PT95422A (pt) 1991-05-22
IE903464A1 (en) 1991-04-10
JP3176615B2 (ja) 2001-06-18
EG19338A (en) 1994-12-30

Similar Documents

Publication Publication Date Title
GB2164856B (en) Adapter for definition of the position of brain structures
GB2206788B (en) 5 ht-3 antagonist for the treatment or reduction of dependence
GR3002756T3 (en) Process for the preparation of folic acid
AU3064184A (en) Improved compositions for the treatment of psoriasis
GB2207672B (en) Sulphonamidothienylcarboxyic acid compounds
HU902444D0 (en) Moisturizing base for the local use of vitamine acid
IT1184271B (it) Composizione farmaceutica contenente un composto beta-bloccante per la profilassi ed il trattamento di disordini cardiaci
ZA867530B (en) Composition for the treatment of acne
EP0319767A3 (en) Process for the preparation of trifluoromethane sulfonique acid chloride
AU6142186A (en) Use of melatonin or related compounds for the treatment of psoriasis
US4931457B1 (en) Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders
ZA907702B (en) The use of alkylphosphoric acid compounds for combatting psoriasis disorders
AU2720388A (en) New therapeutical use of h2-receptor-blocking compounds
GB2202145B (en) Compositions of nedocromil for dermatological use.
ZA886247B (en) Use of a compound for the treatment of schizophrenia
GB2165453B (en) Pharmaceutical agent for the local treatment of psoriasis
GB2157283B (en) Esters of 3,5-diacetylamino-2,4,6-triiodobenzoic acid as x-ray contrast agents
ZA889580B (en) Further hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds
GR870501B (en) Use of malonic acid derivative compounds for increasing cropyield
ZA86370B (en) Arylalkoxyphenyl-allylic alcohols as agents for the treatment of hypersensitive ailments
IL85976A0 (en) Process for the manufacture of derivatives of benzoic acid
ES542331A0 (es) "procedimiento para la produccion de compuestos de bis-qui- nazolina"
EP0272542A3 (en) Agent for the abscission of plant parts
EP0308865A3 (en) Process for the oxydehydrogenation of isobutyric acid
NZ255753A (en) Use of substituted azaspiranes for psoriasis treatment